Shots:

• Bayer will utilize Sensible’s ReDS technology as a biomarker for monitoring lung congestion in a clinical study for patients with heart failure- making Bayer- Sensible's largest customer in Europe
• The ReDS System is used as Point-of-Care device/marker of lung fluid- producing a Continuum of Care for patients with fluid management problems + HF/ recovering from coronary artery diseases
• The ReDS System is a wearable vest- quantifying the amount of lung fluid non-invasively and has received FDA’s 510 (k) & CE marking- currently being commercialized in the US

Ref: PRNewsWire | Image: Retail Design Blog